Plasma levels of norethindrone after I.M. injection of 200 mg norethindrone enanthate
- 30 April 1975
- journal article
- Published by Elsevier BV in Contraception
- Vol. 11 (4), 419-425
- https://doi.org/10.1016/0010-7824(75)90004-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera)Contraception, 1974
- Recurrence of ovulation after daily, oral administration of 10 mg of norethindrone on day 15–22 and on day 8–15 of the human menstrual cycleContraception, 1974
- Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agentContraception, 1973
- Serum LH Concentration in Women under Contraceptive Treatment with Estrogen-Free ProgestagensHormone and Metabolic Research, 1973
- Estrogenic activity in women receiving an injectable progestogen for contraceptionAmerican Journal of Obstetrics and Gynecology, 1972
- The long-term use of injectable norethisterone enanthate as a contraceptiveContraception, 1972
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1971
- Injected Progestogen and LactationBMJ, 1971
- Fertility Inhibition by an Injectable Progestogen Acting for 3 MonthsObstetrics & Gynecology, 1968